Topic: Cytotoxicity

The interview explores the biological mechanism of the spike protein and how systemic dissemination of the vaccine alters the immune response. Dr. Stock explains that the body is forced to choose between producing cytotoxic T cells and antibodies, potentially leaving the lungs vulnerable to infection while increasing the risk of shape-changing "enhancing antibodies."

The segment discusses the European Union's "Graphene Flagship" and the extensive research into graphene-based hydrogels for gene delivery. Karen Kingston cites studies showing that Moderna previously researched graphene oxide for oncology treatments, specifically to induce cell death in ovarian cancer. She notes that FOIA data from Japan shows lipid nanoparticles concentrating in the ovaries and bone marrow of subjects.